These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 8247525)
1. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers. Bousset K; Henriksson M; Lüscher-Firzlaff JM; Litchfield DW; Lüscher B Oncogene; 1993 Dec; 8(12):3211-20. PubMed ID: 8247525 [TBL] [Abstract][Full Text] [Related]
2. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II. Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324 [TBL] [Abstract][Full Text] [Related]
3. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Lüscher B; Larsson LG Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions. Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223 [TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation. Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152 [TBL] [Abstract][Full Text] [Related]
6. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer. Västrik I; Mäkelä TP; Koskinen PJ; Saksela K; Alitalo K Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890 [TBL] [Abstract][Full Text] [Related]
7. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors. Sauvé S; Tremblay L; Lavigne P J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239 [TBL] [Abstract][Full Text] [Related]
8. Max and c-Myc/Max DNA-binding activities in cell extracts. Littlewood TD; Amati B; Land H; Evan GI Oncogene; 1992 Sep; 7(9):1783-92. PubMed ID: 1501888 [TBL] [Abstract][Full Text] [Related]
9. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max. Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719 [TBL] [Abstract][Full Text] [Related]
11. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively. Vervoorts J; Lüscher B Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451 [TBL] [Abstract][Full Text] [Related]
12. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc. Gupta K; Anand G; Yin X; Grove L; Prochownik EV Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Larsson LG; Bahram F; Burkhardt H; Lüscher B Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414 [TBL] [Abstract][Full Text] [Related]
14. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity. Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929 [TBL] [Abstract][Full Text] [Related]
15. c-Myc does not require max for transcriptional activity in PC-12 cells. Ribon V; Leff T; Saltiel AR Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425 [TBL] [Abstract][Full Text] [Related]
16. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1. Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639 [TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation. Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Giorello L; Clerico L; Pescarolo MP; Vikhanskaya F; Salmona M; Colella G; Bruno S; Mancuso T; Bagnasco L; Russo P; Parodi S Cancer Res; 1998 Aug; 58(16):3654-9. PubMed ID: 9721875 [TBL] [Abstract][Full Text] [Related]
19. Max activity is affected by phosphorylation at two NH2-terminal sites. Koskinen PJ; Västrik I; Mäkelä TP; Eisenman RN; Alitalo K Cell Growth Differ; 1994 Mar; 5(3):313-20. PubMed ID: 8018564 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Amati B; Dalton S; Brooks MW; Littlewood TD; Evan GI; Land H Nature; 1992 Oct; 359(6394):423-6. PubMed ID: 1406955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]